Quantification of intratumoural heterogeneity in mice and patients via machine-learning models trained on PET-MRI data.
Prateek KatiyarJohannes SchwenckLeonie FrauenfeldMathew R DivineVaibhav AgrawalUrsula KohlhoferSergios GatidisRoland KontermannAlfred KönigsrainerLeticia Quintanilla-MartinezChristian la FougèreBernhard SchölkopfBernd J PichlerJonathan A DisselhorstPublished in: Nature biomedical engineering (2023)
In oncology, intratumoural heterogeneity is closely linked with the efficacy of therapy, and can be partially characterized via tumour biopsies. Here we show that intratumoural heterogeneity can be characterized spatially via phenotype-specific, multi-view learning classifiers trained with data from dynamic positron emission tomography (PET) and multiparametric magnetic resonance imaging (MRI). Classifiers trained with PET-MRI data from mice with subcutaneous colon cancer quantified phenotypic changes resulting from an apoptosis-inducing targeted therapeutic and provided biologically relevant probability maps of tumour-tissue subtypes. When applied to retrospective PET-MRI data of patients with liver metastases from colorectal cancer, the trained classifiers characterized intratumoural tissue subregions in agreement with tumour histology. The spatial characterization of intratumoural heterogeneity in mice and patients via multimodal, multiparametric imaging aided by machine-learning may facilitate applications in precision oncology.
Keyphrases
- positron emission tomography
- magnetic resonance imaging
- computed tomography
- contrast enhanced
- machine learning
- end stage renal disease
- pet ct
- big data
- electronic health record
- single cell
- pet imaging
- newly diagnosed
- chronic kidney disease
- resistance training
- high fat diet induced
- liver metastases
- diffusion weighted imaging
- palliative care
- peritoneal dialysis
- mass spectrometry
- high resolution
- bone marrow
- cell therapy
- cell proliferation
- artificial intelligence
- stem cells
- replacement therapy
- fluorescence imaging
- metabolic syndrome
- photodynamic therapy
- drug delivery